A university research institute advancing stem cell science and cell and gene therapy development — not a clinic that offers treatment to walk-in patients.
Please read this first: the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA is a research institute, not a treatment clinic. It does not offer stem cell therapy to patients who arrive seeking it. Access to any therapy developed here is through enrollment in a clinical trial, which has eligibility criteria and is not available on request.
The center brings together more than 250 faculty members and 419 trainees across 55 schools and departments at UCLA. Its stated functions are collaborative research across disciplines, investment in early-career scientists, and translation of stem cell discoveries toward clinical application. It operates the Center for Advanced Biotherapies, a 14,000 square foot manufacturing facility built to produce cell and gene therapies to regulatory standards.
Research areas referenced include cancer vaccines, repair of blood system damage, long COVID, and brain cell biology and genetics. Patients interested in participating in research should search registered clinical trials rather than contacting the center for treatment.
Research areas referenced by the center. These are subjects of study, not treatments offered to patients.
The center is located at UCLA in Los Angeles, California, mailing address Box 957357, Los Angeles, California 90095-7357. Its Center for Advanced Biotherapies is a 14,000 square foot manufacturing facility built to regulatory compliance standards.
Not applicable. This is a research institute and does not sell treatment. Clinical trial participation does not typically involve charging the participant for the investigational therapy.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.